Pulse Biosciences, Inc. (PLSE) DCF Valuation

Pulse Biosciences, Inc. (PLSE) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Pulse Biosciences, Inc. (PLSE) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to determine the intrinsic value of Pulse Biosciences, Inc.? Our (PLSE) DCF Calculator incorporates real-world data along with extensive customization features, enabling you to adjust forecasts and enhance your investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 1.4 .7 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 -50.63 -100 -37.66 -37.66 -37.66 -37.66 -37.66
EBITDA -46.8 -48.9 -61.9 -56.7 -42.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 -4363.05 -8100.29 100 20 20 20 20 20
Depreciation 1.2 1.1 1.1 1.4 1.2 .0 .0 .0 .0 .0
Depreciation, % 100 100 80.82 193.57 100 96.16 96.16 96.16 96.16 96.16
EBIT -48.0 -50.0 -63.0 -58.1 -43.6 .0 .0 .0 .0 .0
EBIT, % 100 100 -4443.86 -8293.86 100 20 20 20 20 20
Total Cash 25.4 20.5 28.6 61.1 44.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .1 .0 .0
Account Receivables, % 100 100 4.3 0 100
Inventories .0 .0 5.8 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 410.72 0 100 80 80 80 80 80
Accounts Payable 2.0 1.7 2.9 1.6 1.8 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 204.8 224.71 100 100 100 100 100 100
Capital Expenditure -.6 -.4 -.4 -.4 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 -30.82 -57.29 100 -17.62 -17.62 -17.62 -17.62 -17.62
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -47.0 -49.9 -62.5 -58.5 -43.6 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -44.4 -49.4 -66.5 -53.0 -42.2 -1.8 .0 .0 .0 .0
WACC, % 12.74 12.74 12.74 12.74 12.74 12.74 12.74 12.74 12.74 12.74
PV UFCF
SUM PV UFCF -1.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -35
Equity Value 34
Diluted Shares Outstanding, MM 48
Equity Value Per Share 0.70

What You Will Receive

  • Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-loaded real PLSE financials.
  • Accurate Data: Historical figures and forward-looking projections (displayed in the highlighted cells).
  • Adjustable Forecasts: Modify forecast parameters such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect Pulse Biosciences' valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Interface: Organized for clarity and simplicity, complete with step-by-step guidance.

Key Features

  • 🔍 Real-Life PLSE Financials: Pre-filled historical and projected data for Pulse Biosciences, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Pulse Biosciences’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Pulse Biosciences’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Pulse Biosciences data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Pulse Biosciences’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Pulse Biosciences, Inc. (PLSE)?

  • User-Friendly Interface: Tailored for both novice users and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your financial analysis.
  • Real-Time Feedback: Observe immediate updates to Pulse Biosciences’ valuation as you modify inputs.
  • Preloaded Data: Comes equipped with Pulse Biosciences’ actual financial metrics for swift evaluation.
  • Relied Upon by Experts: Widely utilized by investors and analysts for data-driven decision making.

Who Should Use This Product?

  • Investors: Accurately estimate Pulse Biosciences, Inc.'s (PLSE) fair value before making investment decisions.
  • CFOs: Leverage a professional-grade DCF model for financial reporting and analysis of Pulse Biosciences, Inc. (PLSE).
  • Consultants: Quickly adapt the template for valuation reports for clients focusing on Pulse Biosciences, Inc. (PLSE).
  • Entrepreneurs: Gain insights into financial modeling used by leading biotech firms like Pulse Biosciences, Inc. (PLSE).
  • Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to Pulse Biosciences, Inc. (PLSE).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Pulse Biosciences historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Pulse Biosciences, Inc. (PLSE).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.